Anti-NBAS monoclonal antibody

Pre-made anti-NBAS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NBAS/NBAS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1239-Ab-1/ GM-Tg-hg-IP1239-Ab-2Anti-Human NBAS monoclonal antibodyHuman
GM-Tg-rg-IP1239-Ab-1/ GM-Tg-rg-IP1239-Ab-2Anti-Rat NBAS monoclonal antibodyRat
GM-Tg-mg-IP1239-Ab-1/ GM-Tg-mg-IP1239-Ab-2Anti-Mouse NBAS monoclonal antibodyMouse
GM-Tg-cynog-IP1239-Ab-1/ GM-Tg-cynog-IP1239-Ab-2Anti-Cynomolgus/ Rhesus macaque NBAS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1239-Ab-1/ GM-Tg-felg-IP1239-Ab-2Anti-Feline NBAS monoclonal antibodyFeline
GM-Tg-cang-IP1239-Ab-1/ GM-Tg-cang-IP1239-Ab-2Anti-Canine NBAS monoclonal antibodyCanine
GM-Tg-bovg-IP1239-Ab-1/ GM-Tg-bovg-IP1239-Ab-2Anti-Bovine NBAS monoclonal antibodyBovine
GM-Tg-equg-IP1239-Ab-1/ GM-Tg-equg-IP1239-Ab-2Anti-Equine NBAS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1239-Ab-1/ GM-Tg-hg-IP1239-Ab-2; GM-Tg-rg-IP1239-Ab-1/ GM-Tg-rg-IP1239-Ab-2;
GM-Tg-mg-IP1239-Ab-1/ GM-Tg-mg-IP1239-Ab-2; GM-Tg-cynog-IP1239-Ab-1/ GM-Tg-cynog-IP1239-Ab-2;
GM-Tg-felg-IP1239-Ab-1/ GM-Tg-felg-IP1239-Ab-2; GM-Tg-cang-IP1239-Ab-1/ GM-Tg-cang-IP1239-Ab-2;
GM-Tg-bovg-IP1239-Ab-1/ GM-Tg-bovg-IP1239-Ab-2; GM-Tg-equg-IP1239-Ab-1/ GM-Tg-equg-IP1239-Ab-2
Products NameAnti-NBAS monoclonal antibody
Formatmab
Target NameNBAS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NBAS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1239-Ag-1Recombinant multi-species NBAS/ ILFS2/ NAG protein


    Target information

    Target IDGM-IP1239
    Target NameNBAS
    Gene ID51594,71169,690073,698203,482975,101085115,521982,100072177
    Gene Symbol and Synonyms4933425L03Rik,ILFS2,NAG,NBAS,SOPH
    Uniprot AccessionA2RRP1
    Uniprot Entry NameNBAS_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000151779
    Target ClassificationN/A

    The target: NBAS, gene name: NBAS, also named as ILFS2, NAG, SOPH. This gene encodes a protein with two leucine zipper domains, a ribosomal protein S14 signature domain and a Sec39 like domain. The protein is thought to be involved in Golgi-to-ER transport. Mutations in this gene are associated with short stature, optic nerve atrophy, and Pelger-Huet anomaly. [provided by RefSeq, Oct 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.